Formulation of anastrozole microparticles as biodegradable anticancer drug carriers

AAPS PharmSciTech

Volumn 7, Issue 3, 2006, Pages

  Zidan, Ahmed S ^a,b,c   Sammour, Omaima A ^a   Hammad, Mohammed A ^a   Megrab, Nagia A ^a   Hussain, Muhammad D ^d   Khan, Mansoor A ^c   Habib, Muhammad J ^b  

^a Zagazig University   (Egypt)

^b HOWARD UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF WYOMING   (United States)

Author keywords

Anastrozole; Biodegradation; Breast cancer; Microencapsulation; PLGA

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; CLOMIPRAMINE; DRUG CARRIER; MICROSPHERE; POLYGLACTIN; STABILIZING AGENT;

ARTICLE; BIODEGRADABILITY; BREAST CANCER; CHEMICAL INTERACTION; CHEMICAL MODEL; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG ISOLATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; GAS CHROMATOGRAPHY; INFRARED SPECTROSCOPY; LONG TERM CARE; MASS SPECTROMETRY; MATERIAL STATE; PARTICLE SIZE; PHARMACOLOGICAL PROCEDURES; PROCESS DEVELOPMENT; QUANTITATIVE ASSAY; REFLECTOMETRY; SURFACE PROPERTY; SUSTAINED RELEASE PREPARATION; VISCOSITY;

EID: 33746613577     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070361     Document Type: Article

References (24)

1. Chowdhury S, Ellis PA. Recent advances in the use of aromatase inhibitors for women with postmenopausal breast cancer. J Br Menopause Soc. 2005;11:96-102.
2. Fernández-Carballido A, Herrero-Vanrell R, Molina-Martinez IT, Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration: effect of Labrafil addition on release in vitro. Int J Pharm. 2004;279:33-41.
3. Tuncay M, Calis S, Kas HS, Ercan MT, Peksoy I, Hincal AA. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro:in vivo evaluation. Int J Pharm. 2000;195: 179-188.
4. Bock MJ, Bara I, LeDonne N, Martz A, Dyroff M. Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection. J Chromatogr B Biomed Sci Appl. 1997;700:131-138.
5. Marcos J, de la Torre X, Gonzalez JC, Segura J, Pascual JA. Liquid chromatography clean-up method to improve identification of anabolic agents in human urine by gas chromatography-mass spectrometry. Anal Chim Acta. 2004;522:79-88.
6. Young CR, Dietzsch C, Cerea M, et al. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer. Int J Pharm. 2005;301: 112-120.
7. Sinha VR, Trehan A. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres. Drug Deliv. 2005;12:133-142.
8. Jaganathan KS, Raob YUB, Singh P, et al. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm. 2005;294:23-32.
9. Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres. J Control Release. 2001;75:307-315.
10. Sandor M, Enscore D, Weston P, Mathiowitz E. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Release. 2001;76:297-311.
11. Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-coglycolic acid) microspheres as a novel approach for immunogene delivery. J Control Release. 1999;57:9-18.
12. Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf A: Physicochem Eng. 2001;182:123-130.
13. Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulating variables on size, drug recovery and release kinetics. J Control Release. 2002;83:389-400.
14. Quintanar-Guerrero D, Fessi H, Allémann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm. 1996;143:133-141.
15. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290:137-144.
16. Mateovic T, Kriznar B, Bogataj M, Mrhar A. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsul. 2002;19:29-36.
17. Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J Control Release. 2001;71:53-69.
18. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282:1-18.
19. Arimidex® (Anastrozole) Tablets Prescribing Information. 2002. Wilmington, DE: AstraZeneca. Available at: http://www.fda.gov/medwatch/ SAFETY/2004/Aug_PI/Arimidex_PI.pdf. Accessed: June 13, 2006.
20. Chen S, Singh J. Controlled, delivery of testosterone from smart polymer solution based systems: in vitro evaluation. Int J Pharm. 2005;295:183-190.
21. Crow BB, Borneman AF, Hawkins DL, Smith GM, Nelson KD. Evaluation of in vitro drug release, pH change, and molecular weight degradation of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide). Tissue Eng. 2005;11:1077-1084.
22. Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release. 2002;82:137-147.
23. van de Weert M, Hof R, Weerd J, et al. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release. 2000;68:31-40.
24. Corrigan OI. Thermal analysis of spray dried products. Thermochim Acta. 1995;248:245-258.